1. EachPod

Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma

Author
Dr. Neil Love
Published
Thu 28 Sep 2023
Episode Link
https://hematologic-oncology.captivate.fm/episode/oncology-today-with-dr-neil-love-emerging-role-of-celmods-cereblon-e3-ligase-modulators-and-other-novel-approaches-to-targeting-protein-degradation-pathways-in-multiple-myeloma

Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston discusses the emerging role of CELMoDs and other novel approaches to targeting protein degradation pathways in the treatment of multiple myeloma.

Share to: